Contractor
FRESENIUS KABI, LLC
- UEI
- C2TRNWNQKMD6
- Resolved by
- uei
- Confidence
- 1.000
Active from Feb 27, 2026 to Jul 29, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75A50326F80006 ATROPINE 0.4MGML X 20ML SOLN. FOR INJ., MULTI-DOSE VIALS 8MG AND MIDAZOLAM SOLN. FOR INJ., 5MG/ML, MULTI-DOSE VIALS EO 14398 | Department of Health and Human Services | IL | Jul 29, 2026 | $7,878,120 |
| 36F79725D0145 ADDITION | Department of Veterans Affairs | — | Mar 13, 2026 | — |
| 36E79726D0028 3 LINE ITEMS. FOR USTEKINUMAB SYRINGES/VIALS. AWARDED FOR A BASE YEAR OF 6/14/2026 TO 6/13/2027 PLUS 4 ONE-YEAR OPTION PERIODS. | Department of Veterans Affairs | — | Apr 30, 2026 | — |
| SPE2D326F098W 4571758057!XYLOCAINE 1% VIAL 20ML | Department of Defense | IL | May 6, 2026 | $61 |
| SPE2D326F091Y 4571732328!FUROSEMIDE 100 MG/10 ML VIAL 10ML | Department of Defense | IL | May 5, 2026 | $62 |
| SPE2D326F091W 4571732326!KETOROLAC 30 MG/ML VIALML | Department of Defense | IL | May 5, 2026 | $213 |
| SPE2D326F092U 4571732320!DIPHENHYDRAMINE 50 MG/ML VIALML | Department of Defense | IL | May 5, 2026 | $140 |
| SPE2D326F091U 4571732330!XYLOCAINE 1% VIAL 20ML | Department of Defense | IL | May 5, 2026 | $61 |
| SPE2D326F092B 4571732324!DIPHENHYDRAMINE 50 MG/ML VIALML | Department of Defense | IL | May 5, 2026 | $47 |
| SPE2D326F092T 4571732322!XYLOCAINE 1%-EPI 1:100,000 20ML | Department of Defense | IL | May 5, 2026 | $81 |
| SPE2D326F088B 4571723611!ROCURONIUM 100 MG/10 ML VIAL 10ML | Department of Defense | IL | May 4, 2026 | $184 |
| SPE2D326F087Z 4571723614!KETOROLAC 30 MG/ML VIALML | Department of Defense | IL | May 4, 2026 | $426 |
| SPE2D326F088A 4571723612!FUROSEMIDE 100 MG/10 ML VIAL 10ML | Department of Defense | IL | May 4, 2026 | $249 |
| SPE2D326F089P 4571723609!KETOROLAC 30 MG/ML VIALML | Department of Defense | IL | May 4, 2026 | $320 |
| SPE2D326F087Y 4571723616!DEXAMETHASONE 20 MG/5 ML VIAL 5ML | Department of Defense | IL | May 4, 2026 | $581 |
| SPE2D326F089R 4571723607!DIPHENHYDRAMINE 50 MG/ML VIALML | Department of Defense | IL | May 4, 2026 | $47 |
| SPE2D326F090B 4571801238!DIPHENHYDRAMINE 50 MG/ML VIALML | Department of Defense | IL | May 4, 2026 | $23 |
| SPE2D326F082Q 4571723631!KETOROLAC 30 MG/ML VIALML | Department of Defense | IL | May 1, 2026 | $959 |
| SPE2D326F085P 4571723622!DIPHENHYDRAMINE 50 MG/ML VIALML | Department of Defense | IL | May 1, 2026 | $23 |
| SPE2D326F085X 4571723618!XYLOCAINE 1% VIAL 20ML | Department of Defense | IL | May 1, 2026 | $30 |
| SPE2D326F085V 4571723619!DIPHENHYDRAMINE 50 MG/ML VIALML | Department of Defense | IL | May 1, 2026 | $70 |
| SPE2D326F082R 4571723629!KETOROLAC 30 MG/ML VIALML | Department of Defense | IL | May 1, 2026 | $1,812 |
| SPE2D326F081Z 4571723633!DIPHENHYDRAMINE 50 MG/ML VIALML | Department of Defense | IL | May 1, 2026 | $444 |
| SPE2D326F084R 4571723627!DEXAMETHASONE 120 MG/30 ML VL 30ML | Department of Defense | IL | May 1, 2026 | $577 |
| SPE2D326F084S 4571723626!FUROSEMIDE 100 MG/10 ML VIAL 10ML | Department of Defense | IL | May 1, 2026 | $125 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier C2TRNWNQKMD6, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.